Shu H K, Sneed P K, Shiau C Y, McDermott M W, Lamborn K R, Park E, Ho M, Petti P L, Smith V, Verhey L J, Wara W M, Gutin P H, Larson D A
Department of Radiation Oncology, University of California, San Francisco, San Francisco, California 94143-0226, USA.
Cancer J Sci Am. 1996 Nov-Dec;2(6):335-42.
Radiosurgery has been reported to yield high local control rates for brain metastases. However, further work is needed to define which subgroups of patients may benefit from this treatment modality.
We reviewed 116 patients who underwent stereotactic radiosurgery for initial management or recurrence of solitary or multiple brain metastases from September 1991 through December 1994 at the University of California, San Francisco. Survival time and time to local-regional failure were calculated using the Kaplan-Meier method. Univariate and multivariate analyses were performed using the Cox proportional hazards model.
Median survival was 40 weeks from radiosurgery. In multivariate analysis, smaller total tumor volume, absence of extracranial metastases, higher Karnofsky score, and age < or = 70 had a positive effect on survival. In patients initially managed for brain metastases, the addition of whole brain radiotherapy to radiosurgery had no significant effect on survival. Although the presence of multiple metastases was associated with a significantly worse survival rate in patients initially managed with radiosurgery in univariate analysis, it was not as a significant factor in multivariate analysis. An analysis of patients within this series treated with radiosurgery who would have been eligible for Patchell's study on the role of surgery in the treatment of solitary brain metastasis revealed a favorable median survival of 70 weeks.
We conclude that radiosurgical treatment of brain metastases results in survival times that compare favorably with the historic experience in patients treated with whole brain radiotherapy alone or with surgical resection. In patients presenting initially with brain metastases, radiosurgery alone may yield survival results equivalent to radiosurgery with whole brain radiotherapy, but intracranial control and quality of life also need to be evaluated. Also, the presence of multiple brain metastases should not be a contraindication for the use of radiosurgery given the good survival achieved with such patients in this series. Each such case should therefore be evaluated based on other factors such as patient's age, Karnofsky score and systemic disease.
据报道,放射外科手术对脑转移瘤有较高的局部控制率。然而,需要进一步研究以确定哪些亚组患者可能从这种治疗方式中获益。
我们回顾了1991年9月至1994年12月在加利福尼亚大学旧金山分校接受立体定向放射外科手术治疗单发或多发脑转移瘤初治或复发的116例患者。采用Kaplan-Meier法计算生存时间和局部区域失败时间。使用Cox比例风险模型进行单因素和多因素分析。
放射外科手术后的中位生存期为40周。多因素分析显示,较小的肿瘤总体积、无颅外转移、较高的卡氏评分以及年龄≤70岁对生存有积极影响。对于初治脑转移瘤的患者,在放射外科手术基础上加用全脑放疗对生存无显著影响。虽然在单因素分析中,多发转移的存在与初治采用放射外科手术的患者生存率显著降低相关,但在多因素分析中并非显著因素。对本系列中接受放射外科手术且符合Patchell关于手术在单发脑转移瘤治疗中作用研究条件的患者进行分析,其有利的中位生存期为70周。
我们得出结论,脑转移瘤的放射外科治疗所产生的生存时间与单纯全脑放疗或手术切除患者的历史经验相比具有优势。对于初发脑转移瘤的患者,单纯放射外科手术可能产生与放射外科手术联合全脑放疗相当的生存结果,但颅内控制和生活质量也需要评估。此外,鉴于本系列中此类患者取得了良好的生存效果,多发脑转移瘤的存在不应成为放射外科手术使用的禁忌证。因此,每个此类病例都应根据患者年龄、卡氏评分和全身疾病等其他因素进行评估。